Sotera Health Company (SHC)
USD 12.38
(2.31%)
USD 12.38
(2.31%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 51.98 Million USD | 39.95% |
| 2022 | 37.14 Million USD | -31.58% |
| 2021 | 54.28 Million USD | 59.24% |
| 2020 | 34.09 Million USD | -8.83% |
| 2019 | 37.39 Million USD | -0.54% |
| 2018 | 37.59 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 61.75 Million USD | 12.08% |
| 2024 Q1 | 55.09 Million USD | 5.98% |
| 2024 Q3 | 53.64 Million USD | -13.13% |
| 2023 Q4 | 51.98 Million USD | 37.08% |
| 2023 Q2 | 42.1 Million USD | -9.92% |
| 2023 Q1 | 46.73 Million USD | 25.82% |
| 2023 Q3 | 37.92 Million USD | -9.92% |
| 2023 FY | 51.98 Million USD | 39.95% |
| 2022 Q3 | 37.15 Million USD | -6.3% |
| 2022 FY | 37.14 Million USD | -31.58% |
| 2022 Q4 | 37.14 Million USD | -0.02% |
| 2022 Q2 | 39.65 Million USD | -13.24% |
| 2022 Q1 | 45.7 Million USD | -15.82% |
| 2021 Q3 | 37.49 Million USD | 4.97% |
| 2021 Q4 | 54.28 Million USD | 44.78% |
| 2021 FY | 54.28 Million USD | 59.24% |
| 2021 Q1 | 33.37 Million USD | -2.11% |
| 2021 Q2 | 35.72 Million USD | 7.03% |
| 2020 Q2 | 30.34 Million USD | 0.0% |
| 2020 FY | 34.09 Million USD | -8.83% |
| 2020 Q3 | 29.15 Million USD | -3.94% |
| 2020 Q4 | 34.09 Million USD | 16.95% |
| 2020 Q1 | - USD | -100.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 37.39 Million USD | -0.54% |
| 2019 Q4 | 37.39 Million USD | 0.0% |
| 2018 FY | 37.59 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | - USD | -Infinity% |
| Biodesix, Inc. | 1.4 Million USD | -3613.214% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -281143.237% |
| Castle Biosciences, Inc. | 7.94 Million USD | -554.558% |
| DarioHealth Corp. | 5.06 Million USD | -926.966% |
| Exact Sciences Corporation | 127.47 Million USD | 59.219% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | 86.33% |
| Illumina, Inc. | 587 Million USD | 91.144% |
| Intelligent Bio Solutions Inc. | 777.53 Thousand USD | -6585.855% |
| iSpecimen Inc. | - USD | -Infinity% |
| Standard BioTools Inc. | 20.53 Million USD | -153.178% |
| 23andMe Holding Co. | 12.46 Million USD | -317.048% |
| Medpace Holdings, Inc. | 1.00 USD | -5198499900.0% |
| NeoGenomics, Inc. | 24.15 Million USD | -115.205% |
| Inotiv, Inc. | 56.1 Million USD | 7.338% |
| Psychemedics Corporation | 1.00 USD | -5198499900.0% |
| Prenetics Global Limited | 3.12 Million USD | -1562.575% |
| Precipio, Inc. | 384 Thousand USD | -13437.76% |
| RadNet, Inc. | 1.00 USD | -5198499900.0% |
| Star Equity Holdings, Inc. | 3.42 Million USD | -1420.029% |
| Exagen Inc. | 2.87 Million USD | -1710.693% |
| Natera, Inc. | 40.75 Million USD | -27.542% |
| Aspira Women's Health Inc. | 227 Thousand USD | -22800.881% |
| Neogen Corporation | 189.26 Million USD | 72.534% |
| Myriad Genetics, Inc. | 20.1 Million USD | -158.632% |
| ICON Public Limited Company | 1.00 USD | -5198499900.0% |
| Bionano Genomics, Inc. | 22.89 Million USD | -127.078% |
| CareDx, Inc | 19.47 Million USD | -166.987% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 32.06 Million USD | -62.134% |
| Guardant Health, Inc. | 61.94 Million USD | 16.083% |
| BioNexus Gene Lab Corp. | 1.13 Million USD | -4469.025% |
| Fulgent Genetics, Inc. | 5.82 Million USD | -792.14% |
| Sera Prognostics, Inc. | - USD | -Infinity% |
| OPKO Health, Inc. | 65.69 Million USD | 20.872% |
| Personalis, Inc. | 5.66 Million USD | -818.301% |
| Applied DNA Sciences, Inc. | 330.02 Thousand USD | -15651.742% |
| Star Equity Holdings, Inc. | 3.42 Million USD | -1420.029% |
| MDxHealth SA | 2.77 Million USD | -1770.637% |
| Prenetics Global Limited | 3.12 Million USD | -1562.575% |
| ENDRA Life Sciences Inc. | 2.62 Million USD | -1881.993% |
| Mainz Biomed B.V. | 613.63 Thousand USD | -8371.607% |
| Trinity Biotech plc | 19.93 Million USD | -160.799% |
| Neuronetics, Inc. | 8.09 Million USD | -542.345% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -281143.237% |